PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $270,000 | -60.8% | 6,962 | -53.7% | 0.38% | -41.9% |
| Q3 2018 | $689,000 | +32.8% | 15,035 | +71.4% | 0.64% | +35.5% |
| Q2 2018 | $519,000 | +6.6% | 8,771 | +22.6% | 0.48% | -6.7% |
| Q1 2018 | $487,000 | +8.2% | 7,157 | +57.1% | 0.51% | +10.9% |
| Q4 2017 | $450,000 | -8.0% | 4,555 | +11.6% | 0.46% | -23.2% |
| Q3 2017 | $489,000 | +134.0% | 4,083 | +70.6% | 0.60% | +89.6% |
| Q2 2017 | $209,000 | – | 2,393 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |